Ozempic Maker Novo Nordisk Faces Massive Lawsuits Over Causing Blindness – Investors Beware
In this Market Mondays clip, Rashad Bilal, Troy Millings, and Ian Dunlap dive deep into the multi-billion dollar lawsuits facing pharmaceutical giants Novo Nordisk and Eli Lilly over their blockbuster drug Ozempic and similar weight loss treatments. With over 2,000 federal lawsuits piling up—worth more than $2 billion—the team explores the risks and side effects, including rare vision problems, stomach paralysis, and severe kidney damage, now at the center of these legal battles.
Rashad shares his early warnings about the rapid rise of Ozempic and reflects on the cyclical history of “miracle”…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.